Kernicterus and the molecular mechanisms of bilirubin-induced CNS injury in newborns

NeuroMolecular Medicine

Volumn 8, Issue 4, 2006, Pages 513-529

  Watchko, Jon F ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Apoptosis; Bilirubin; Excitotoxic injury; Kernicterus; Necrosis; Neurotoxicity

Indexed keywords

BILIRUBIN; CALCIUM; MITOGEN ACTIVATED PROTEIN KINASE;

APOPTOSIS; BASAL GANGLION; BILIRUBIN BLOOD LEVEL; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CELL DEATH; CENTRAL NERVOUS SYSTEM DISEASE; COCHLEA; DISEASE PREDISPOSITION; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; EXCITOTOXICITY; EYE MOVEMENT CONTROL; GLIA CELL; HUMAN; KERNICTERUS; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; MOLECULAR BIOLOGY; NERVE CELL; NEUROTOXICITY; PATHOGENESIS; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; SIGNAL TRANSDUCTION;

EID: 33749636448     PISSN: 15351084     EISSN: None     Source Type: Journal    
DOI: 10.1385/NMM:8:4:513     Document Type: Review

References (123)

1. Ahdab-Barmada M. (1983) Neonatal kernicterus: neuropathologic diagnosis, in Hyperbilirubinemia in the Newborn, Levine R. L., Maisels M. J., eds., Ross Laboratories, Columbus, OH, pp. 2-10.
2. Ahdab-Barmada M. (2000) The neuropathology of kernicterus: definitions and debate, in Neonatal Jaundice, Maisels M. J., Watchko J. F., eds., Harwood Academic Publishers, Amsterdam, pp. 75-88.
3. Ahdab-Barmada M. and Moossy J. (1984) The neuropathology of kernicterus in the premature neonate: Diagnostic problems. J. Neuropathol. Exp. Neurol. 43, 45-52.
4. Akin E., Clower B., Tibbs R., Tang J., and Zhang J. (2002) Bilirubin produces apoptosis in cultured bovine brain endothelial cells. Brain Res. 931, 168-175.
5. Bhutani V. K., Johnson L. H., Maisels M. J., et al. (2004) Kernicterus: epidemiological strategies for its prevention through systems-based approaches. J. Perinatol. 24, 650-662.
6. Bonfoco E., Krainc D., Ankarcrona M., Nicotera P., and Lipton S. A. (1995) Apoptosis and necrosis: Two distinct events induced, respectively, by mild and intense insults with N-Methyl-D-Aspartate or nitric-oxide superoxide in cortical cell-cultures. Proc. Natl. Acad. Sci. USA 92, 7162-7166.
7. Brito M.A., Brites D., and Butterfield D. A. (2004) A link between hyperbilirubinemia, oxidative stress and injury to neocortical synaptosomes. Brain Res. 1026, 33-43.
8. Brodersen R. (1979) Bilirubin: solubility and interactions with albumin and phospholipid. J. Biol. Chem. 254, 2364-2369.
9. Brodersen R. (1982) Physical chemistry of bilirubin: binding to macromolecules and membranes, in Bilirubin Chemistry, Heirwegh K. P. M. and Brown S. B., eds., CRC Press, Inc., Boca Raton, pp. 75-123.
10. Brown A. K. and Johnson L. (1996) Loss of concern about jaundice and the reemergence of kernicterus in full term infants in the era of managed care, in Yearbook of Neonatal and Perinatal Medicine, Fanaroff A. A., Klaus M. H., eds., Mosby Yearbook, St Louis, Missouri, pp. xvii-xxviii.
11. Byers R. K., Paine R. S., and Crothers B. (1955) Extrapyramidal cerebral palsy and hearing loss following erthroblastosis. Pediatrics 15, 248-254.
12. 2+/calmodulin- dependent kinase II activity in vitro. Pediatr. Res. 38, 949-954.
13. 2+/calmodulin kinase II in the cerebellum of jaundiced Gunn rats during development: a quantitative light microscopic analysis. Acta Neuropathol. (Berl.) 99, 393-401.
14. Coskun A., Yikilmaz A., Kumandas S., Karahan O. I., Akcakus M., and Manav A. (2005) Hyperintense globus pallidus on T1-weighted MR imaging in acute kernicterus: is it common or rare? Eur. Radiol. 15, 1263-1267.
15. Cowger M. L. (1971) Mechanisms of bilirubin toxicity on tissue culture cells: factors that affect toxicity, reversibility by albumin, and comparison with other respiratory poisons and surfactants. Biochem. Med. 5, 1-6.
16. Curtin S. C. and Kozak L. J. (1998) Decline in US cesarean delivery rate appears to stall. Birth 25, 259-262.
17. Daood M. J. and Watchko J. F. (2006) Calculated in vivo free bilirubin levels in the central nervous system of Gunn rat pups. Pediatr. Res. in press.
18. Day R. L. (1954) Inhibition of brain respiration in vitro by bilirubin. Reversal of inhibition by various means. Proc. Soc. Exper. Biol. Med. 85, 261-264.
19. Diamond I. and Schmid R. (1967) Oxidative phosphorylation in experimental bilirubin encephalpathy. Science 155, 1288-1289.
20. Durkin J. P., Tremblay R., Chakravarthy B., Mealing G., Morley P., and Song D. (1997) Evidence that the early loss in membrane protein kinase C is a necessary step in the excitatory amino acid-induced death of primary cortical neurons. J. Neurochem. 68, 1400-1412.
21. Durkin J. P., Tremblay R., Buchan A., et al. (1996) An early loss in membrane protein kinase C activity precedes the excitatory amino acid-induced death of primary cortical neurons. J. Neurochem. 66, 951-962.
22. Ebbesen F. (1982) Low reserve albumin for binding of bilirubin in neonates with deficiency of bilirubin excretion and bronze baby syndrome. Acta Paediatr. Scand. 71, 415-420.
23. Ebbesen F. (2000) Recurrence of kernicterus in term and near-term infants in Denmark. Acta Paediatr. 89, 1213-1217.
24. Ernster L. (1961) The mode of action of bilirubin on mitochondria, in Kernicterus, Sass-Kortsak A., ed., University of Toronto Press, Toronto, pp. 174-192.
25. Evans P. R. and Polani N. (1950) The neurologic sequelae of Rh sensitization. Quart. J. Med. 19, 129-149.
26. Fernandes A., Falcao A. S., Silva R. F. M., Brito M. A., and Brites D. (2004a) Role of TNFα and biological modifiers on cytokine production after astrocyte exposure to bilirubin: relationship to NF-kB. Pediatr. Res. 55, 473A.
27. Fernandes A., Silva R. F. M., Falcao A. S., Brito M. A., and Brites D. (2004b) Cytokine production, glutamate release and cell death in rat cultured astrocytes treated with unconjugated bilirubin and LPS. J. Neuroimmunol. 153, 64-75.
28. Fernandes A., Falcao S., Gordo C., et al. (2005) Dissecting astrocyte reactivity by unconjugated bilirubin: evidence for a biphasic response. PAS 57, 2255.
29. Gartner L. M., Snyder R. N., Chabon R. S., and Bernstein J. (1970) Kernicterus: high incidence in premature infants with low serum bilirubin concentrations. Pediatrics 45, 906-917.
30. Gennuso F., Fernetti C., Tirolo C., et al. (2004) Bilirubin protects astrocytes from its own toxicity by inducing up-regulation and translocation of multidrug reisistance-associated protein 1 (Mrp1). Proc. Natl. Acad. Sci. USA 101, 2470-2475.
31. Greenamyre T., Penney J. B., Young A. B., Hudson C., Silverstein F. S., and Johnston M. V. (1987) Evidence for transient perinatal glutaminergic innervation of globus pallidus. J. Neurosci. 7, 1022-1030.
32. Grobler J. M. and Mercer M. J. (1997) Kernicterus associated with elevated predominantly direct-reacting bilirubin. South Amer. Med. J. 87, 1146.
33. Groenendaal F., van der Grond J., and de Vries L. S. (2004) Cerebral metabolism in severe neonatal hyperbilirubinemia. Pediatrics 114, 291-294.
34. Grojean S., Koziel V., Vert P., and Daval J. L. (2000) Bilirubin induces apoptosis via activation of NMDA receptors in developing rat brain neurons. Exp. Neurol. 166, 334-341.
35. Hackney D. D. (1980) Photodynamic action of bilirubin on the inner mitochondrial membrane: implications for the organization of the mitochondrial ATPase. Biochem. Biophys. Res. Commum. 94, 875-880.
36. Hanko E., Hansen T. W. R., Almaas R., Lindstad J., and Rootwelt T. (2005) Bilirubin induces apoptosis and necrosis in human NT2-N neurons. Pediatr. Res. 57, 179-184.
37. Hanko E., Hansen T. W. R., Almaas R., Paulsen R., and Rootwelt T. (2006) Synergistic protection of a general caspase inhibitor and MK-801 in bilirubin-induced cell death in human NT2-N neurons. Pediatr. Res. 59, 72-77.
38. Hansen T. W. R. (2000) The pathophysiology of bilirubin toxicity, in Neonatal Jaundice, Maisels M. J. and Watchko, J. F., eds., Harwood Academic Publishers, Amsterdam, The Netherlands, pp. 89-104.
39. Hansen T. W. R. (2002) Kernicterus: an international perspective. Semin Neonatol 7, 103-109.
40. Hansen T. W. R. and Bratlid D. (1986) Bilirubin and brain toxicity. Acta Paediatr. Scand. 75, 513-522.
41. 3H] bilirubin. Pediatr. Res. 49, 203-207.
42. Hansen T. W. R., Oaulsen O., Gjerstad L., and Bratlid D. (1988) Short-term exposure to bilirubin reduces synaptic activation in rat transverse hippocamal slices. Pediatr. Res. 23, 453-456.
43. Hoffman D. J., Zaneli S. A., Kubin J., Mishra O. P., and Delivoria-Papadopoulis M. (1996) The in vivo effect of bilirubin on the N-methyl-D-aspartate receptor/ion channel complex in the brains of newborn piglets. Pediatr Res 40, 804-808.
44. Hoon A. H., Reinhardt E. M., Keley R. I., et al. (1997) Brain magnetic resonance imaging in suspected extrapyramidal cerebral palsy: observations in distinguishing genetic-metabolic from acquired causes. J. Pediatr. 131, 240-245.
45. Johnston M. V. (2005) Excitotoxicity in perinatal brain injury. Brain Pathol. 15, 234-240.
46. Johnson L. and Boggs T. R. (1974) Bilirubin-dependent brain damage: incidence and indications for treatment, in Phototherapy in the Newborn: An Overview, Odell G. B., Schaffer R. and Simopoulos A. P., eds, National Academy of Sciences, Washington, D.C., pp. 122-149.
47. Johnston M. V. and Hoon A. H. (2000) Possible mechanisms in infants for selective basal ganglia damage from asphyxia, kernciterus, or mitochondrial encephalopathies. J. Child. Neurol. 15, 588-591.
48. Johnston M. V. and Ishiwa S. (1995) Ischemia and excitotoxins in development. Mental Retardation and Developmental Disabilities Research Reviews 1, 193-200.
49. Kaplan M. and Hammerman C. (2004) Understanding and preventing severe hyperbilirubinemia: is bilirubin neurotoxicity really a problem in the developed world? Clin. Perinatol. 31, 555-575.
50. Kaplan M. and Hammerman C. (2005) Bilirubin and the genome: The hereditary basis of unconjugated neonatal hyperbilirubinemia. Curr. Pharmacogen. 3, 21-42.
51. Kaplan M., Hammerman C., and Maisels M. J. (2003) Bilirubin genetics for the nongeneticist: hereditary defects of neonatal bilirubin conjugation. Pediatrics 111, 886-893.
52. Karp W. B. (1979) Biochemical alterations in neonatal hyperbilirubinemia and bilirubin encephalopathy: a review. Pediatrics 64, 361-368.
53. Kaul R., Bjpai V. K., Shipstone A. C., Kaul H. K., and Murti C. R. K. (1981) Bilirubin-induced erythrocyte membrane cytoxicity. Exp. Mol. Pathol. 34, 290-298.
54. Keshavan P., Schwemberger S. J., Smith D. L. H., Babcock G. F., and Zucker S. D. (2004) Unconjugated bilirubin induces apoptosis in colon cancer cells by triggering mitochondrial depolarization. Int. J. Cancer 112, 433-445.
55. Leist M. and Nicotera P. (1998) Apoptosis, excitotoxicity, and neuropathology. Exp. Cell Res. 239, 183-201.
56. Lin S., Yan C., Wei X., Paul S. M., and Du Y. (2003) p38 MAP kinase mediates bilirubin-induced death of cultured rat cerebellar granule neurons. Neurosci. Lett. 353, 209-212.
57. Lin S., Wei X., Bales K. R., et al. (2005) Minocycline blocks bilirubin neurotoxicity and prevents hyperbilirubinemia-induced cerebellar hypoplasia in the Gunn rat. Eur. J. Neurosci. 22, 21-27.
58. MacDonald M. G. (1995) Hidden risks: early discharge and bilirubin toxicity due to glucose-6-phosphate dehydrogenase deficiency. Pediatrics 96, 734-738.
59. th International Congress of Neuropathology, vol. 3, Jacob H., ed., Georg Thieme Verlag, Stuttgart, pp.83-89.
60. Maisels M. J. and Newman T. B. (1995) Kernicterus in otherwise healthy, breast-fed term newborns. Pediatrics 96, 730-733.
61. Majoie C. B., Akkerman E. M., Blank C., Barth P. G., Poll-The B. T., and den Heeten G. J. (2002) Mitochondrial encephalopathy: comparison of conventional MR imaging with diffusion-weighted and diffusion tensor imaging: case report. A.J.N.R. Am. J. Neuroradiol. 23, 813-816.
62. Martich-Kriss V., Kollias S. S., and Ball W. S. (1995) MR findings in kernicterus. Am. J Neuroradiol. 16, 819-821.
63. McDonald J. W. and Johnston M. V. (1990) Physiological and pathological roles of excitatory amino acids during central nervous system development. Brain Res. Rev. 15, 41-70.
64. McDonald J. W., Shapiro S. M., Silverstein F. S., and Johnston M. V. (1998) Role of glutamate recpetor-mediated excitotoxicity in bilirubin-induced brain injury in the Gunn rat model. Exp. Neurol. 150, 21-29.
65. Merhar S. L. and Gilbert D. L. (2005) Clinical (video) findings and cerebrospinal fluid neurotransmitters in 2 children with severe chronic bilirubin encephalopathy, including a former preterm infant without marked hyperbilirubinemia. Pediatrics 116, 1226-1230.
66. Nilsen S. T., Finne P. H., Bergsjo P., and Stamnes O. (1984) Males with neonatal hyperbilirubinemia examined at 18 years of age. Acta Paediatr. Scand. 73, 176-180.
67. Notter M. F. D. and Kendig J. W. (1986) Differential sensitivity of neural cells to bilirubin toxicity. Exp. Neurol. 94, 670-682.
68. Novelli A., Reily J. A., Lysko P. G., and Henneberry R. C. (1988) Glutamate becomes neurotoxic via NMDA receptors when intracellular energy levels are reduced. Brain Res. 451, 205-212.
69. Oakden W. K., Moore A. M., Blaser S., and Noseworthy M. D. (2005) 1H MR spectroscopic characteristic of kernicterus: a possible metabolic signature. AJNR Am. J. Neuroradiol. 26, 1571-1574.
70. Oakes G. H. and Bend J. R. (2005) Early steps in bilirubin-mediated apoptosis in murine hepatoma (Hepa 1c1c7) cells are characterized by aryl hydrocarbon receptor-independent oxidative stress and activation of the mitiochondrial pathway. J. Biochem. Mol. Toxicol. 19, 244-255.
71. O'Callaghan A. and Duggan P. F. (1984) Possible biochemical basis for bilirubin neurotoxicity. Biochem. Soc. Trans. 12, 483-483.
72. Ochoa E. L., Wennberg R. P., An Y., et al. (1993) Interactions of bilirubin with isolated presynaptic nerve terminals: functional effects on the uptake and release of neurotransmitters. Cell Molec. Neurobiol. 13, 69-86.
73. Ostrow J. D., Pascolo L., and Tiribelli C. (2003) Reassessment of the unbound concentration of unconjugated bilirubin in relation to neurotoxicity in vitro. Pediatr. Res. 54, 98-104.
74. Ozmert E., Erdem G., Topcu M., et al. (1996) Long-term follow-up of indirect hyperbilirubinemia in full-term Turkish infants. Acta Paeditr. 85, 1440-1444.
75. Paschen W. (2003) Endoplasmic reticulum: a primary target in various acute disorders and degenerative diseases of the brain. Cell Calcium 34, 365-383.
76. Penn A. A., Enzmann D. R., Hahn J. S., and Stevenson D. K. (1994) Kernicterus in a full term infant. Pediatrics 93, 1003-1006.
77. Perlstein M. A. (1960) The late clinical syndrome of posticteric encephalopathy. Pediatr. Clin. North. Am. 7, 665-687.
78. Rice A. C. and Shapiro S. M. (2005) Apoptosis in the Gunn rat model of kernicterus. PAS 57, 1269.
79. Rigato I., Pascolo L., Fernetti C., Ostrow J. D., and Tiribelli C. (2004) The human multidrug-resistance associated protein MRP1 mediates ATP-dependent transport of unconjugated bilirubin. Biochem. J. 383, 335-341.
80. Rodrigues C. M. P., Sola S., and Brites D. (2002a) Bilirubin induces apoptosis via the mitochondrial pathway in developing rat brain neurons. Hepatology 35, 1186-1195.
81. Rodrigues C. M. P., Sola S., Castro R. E., Laires P. A., Brites D., and Moura J. J. G. (2002b) Perturbation of membrane dynamics in nerve cells as an early event during bilirubin-induced apoptosis. J. Lipid Res. 43, 885-894.
82. Rodrigues C. M., Sola A., Silva R., and Brites D. (2000) Bilirubin and amyloid-beta peptide induce cytochrome c release through mitochondrial membrane permeabilization. Mol. Med. 6, 936-946.
83. Roy-Chowdhury J., Huang T., Kesari K., Lederstein M., Arias I. M., and Roy-Chowdhury N. (1991) Molecular basis for the lack of bilirubin-specific and 3-methylcholanthrene inducible UDP-glucuronosyltransferase activities in Gunn rats. J. Biol. Chem. 266, 18,294-18,298.
84. Ryan M. E. and Ashley R. A. (1998) How do tetraclyclines work? Adv. Dent. Res. 12, 149-151.
85. Ryan A. S., Wenjun Z., and Acosta A. (2002) Breast-feeding continues to increase into the new millennium. Pediatrics 110, 1103-1109.
86. Sano K., Nakamura H., and Matsuo T. (1985) Mode of inhibition of bilirubin on protein kinase C. Pediatr. Res. 19, 587-590.
87. Sarna J. R. and Hawkes R. (2003) Patterned Purkinje cell death in the cerebellum. Prog. Neurobiol. 70,473-507.
88. Schenker S., McCandless D. W., and Zollman P. E. (1966) Studies on cellular toxicity of unconjugated bilirubin in kernicteric brain. J. Clin. Invest. 45, 1213-1220.
89. Schutta H. S. and Johnson L. (1971) Electron microscopic observations on acute bilirubin encephalopathy in Gunn rats induced by sulfadimethoxine. Lab. Invest. 24, 82-89.
90. Schutta H. S., Johnson L., and Neville M. E. (1970) Mitochondrial abnormalities in bilirubin encephalopathy. J. Neuropathol. Exp. Neurol. 29, 296-304.
91. Seubert J. M., Darmon A. J., El-Kadi A. O. S., D'Souza J. A., and Bend J. R. (2002) Apoptosis in murine hepatoma Hepa 1c1c7 wild type, C12, and C4 cells mediated by bilirubin. Mol. Pharmacol. 62, 257-264.
92. Shaia W. T., Shapiro S. M., Heller A. J., Galiani D. L., Sismanis A., and Spencer R. F. (2002) Immunohistochemical localization of calcium-binding proteins in the brainstem vestibular nuclei of the jaundiced Gunn rat. Hear. Res. 173, 82-90.
93. Shapiro S. M. (2003) Bilirubin toxicity in the developing nervous system. Pediatr. Neurol. 29, 410-421.
94. Shapiro S. M., Geiger A. S., O'Tuama L. A., and Baron M. S. (2005) Abnormalities on magnetic resonance imaging (MRI) in children with kernciterus. PAS 57, 1262.
95. Silva R. F. M., Rodrigues C. M. P., and Brites D. (2001a) Bilirubin-induced apoptosis in cultured rat neural cells is aggravated by cheonodeoxycholic acid but prevented by urodeoxycholic acid. J. Hepatol. 34, 402-408.
96. Silva R. F. M., Mata L. M., Gulbenkian S., and Brites D. (2001b) Endocytosis in rat cultured astrocytes is inhibitied by unconjugated bilirubin. Neurochem. Res. 26, 793-800.
97. Silva R. F. M., Mata L. M., Gulbenkian S., Brito M. A., Tiribelli C., and Brites D. (1999) Inhibition of glutamate uptake by unconjugated bilirubin in cultured cortical rat astrocytes: role of concentration and pH. Biochem. Biophys. Res. Commun. 265, 67-72.
98. Silverman W. A., Andersen D. H., Blanc W. A., and Crozier D. N. (1956) A difference in mortality rate and incidence of kernicterus among premature infants allotted to two prophylactic antibacterial regimens. Pediatrics 18, 614-625.
99. Slemmer J. E., De Zeeuw C. I., and Weber J. T. (2005) Don't get too excited: mechanisms of glutamate-mediated Purkinje cell death. Prog. Brain Res. 148, 367-390.
100. Spencer R. F., Shaia W. T., Gleason A. T., Sismanis A., and Shapiro S. M. (2002) Changes in calcium-binding protein expression in the auditory brain-stem nuclei of the jaundiced Gunn rat. Hear. Res. 171, 129-141.
101. Talafant E. (1971) Bile pigment phospholipid interactions. Biochim. Biophys. Acta 231, 394-398.
102. Tiribelli C. and Ostrow J. D. (2005) The molecular basis of bilirubin encephalopathy and toxicity: report of an EASL single topic conference, Trieste, Italy, 1-2 October, 2004. J. Hepatol. 43, 156-166.
103. Valaes T. (1994) Severe neonatal jaundice associated with glucose-6-phosphate dehydrogenase deficiency: pathogenesis and global epidemiology. Acta Paediatr. 83(suppl 394), 58-76.
104. Valaes T. (2000) Neonatal jaundice in glucose-6-phosphate dehydrogenase deficiency, in Neonatal Jaundice, Maisels M. J. and Watchko, J. F., eds., Harwood Academic Publishers, Amsterdam, pp. 67-72.
105. Vaughan III V. C., Allen F. H., and Diamond L. K. (1950) Erythroblastosis fetalis. IV. Further observations on kernicterus. Pediatrics 6, 706-716.
106. Vazquez J., Garcia-Calvo M., Valdivieso F., Mayor F., and Mayor Jr. F. (1988) Interaction of bilirubin with the synaptosomal plasma membrane. J. Biol. Chem. 263, 1255-1265.
107. Vogt M. T. and Basford R. E. (1968) The effect of bilirubin on energy metabolism of brain mitochondria. J. Neurochem. 15, 1313-1320.
108. Warr O., Mort D., and Attwell D. (2000) Bilirubin does not modulate ionotropic glutamate receptors or glutamate transporters. Brain. Res. 879, 13-16.
109. Watchko J. F. (2000a) The clinical sequelae of hyperbilirubinemia, in Neonatal Jaundice, Maisels M. J. and Watchko J. F., eds, Harwood Academic Publishers, Amsterdam, pp. 115-135.
110. Watchko J. F. (2000b) Indirect hyperbilirubinemia in the neonate, in Neonatal Jaundice, Maisels M. J. and Watchko J. F., eds, Harwood Academic Publishers, Amsterdam, pp. 51-72.
111. Watchko J. F. (2005a) Bilirubin induced apoptosis in vitro: insights for kernciterus. Pediatr. Res. 177-178.
112. Watchko J. F. (2005b) Genetics and the risk of neonatal hyperbilirubinemia. Pediatr. Res. 56, 677-678.
113. Watchko J. F. (2005c) Vigintiphobia revisited. Pediatrics 115, 1747-1753.
114. Watchko J. F. and Oski F. A. (1992) Kernicterus in preterm newborns: past, present, and future. Pediatrics 90, 707-715.
115. Watchko J. F., Daood M. J., and Biniwale M. (2002) Understanding neonatal hyperbilirubinemia in the era of genomics. Semin. Neonatol. 7, 143-152.
116. Watchko J. F., Daood M. J., and Hansen T. W. R. (1998) Brain bilirubin content is increased in P-glyco-protein deficient transgenic null mutant mice. Pediatr. Res. 44, 763-766.
117. Watchko J. F., Ziegler J., Daood M. J., and Balkundi D. (2003) Inhibition of human MDR1 P-glycoprotein increases bilirubin-induced cell apoptosis in vitro. Pediatr. Res. 53, 400A.
118. Wennberg R. P., Ahlfors C. E., and Rasmussen L. F. (1979) The pathochemistry of kernicterus. Early Hum. Dev. 3, 353-372.
119. Wennberg R. P., Johansson B. B., Folbergrova J., and Siesjo B. K. (1991) Bilirubin-induced changes in brain energy metabolism after osmotic opening of the blood-brain barrier. Pediatr. Res. 30, 473-478.
120. Yokochi K. (1995) Magnetic resonance imaging in children with kernciterus. Acta Paediatr. 84, 937-939.
121. Zetterstrom R. and Ernster L. (1956) Bilirubin, an uncoupler of oxidative phosphorylation in isolated mitochondria. Nature 178, 1335-1337.
122. Ziegler U. and Groscurth P. (2004) Morphological features of cell death. News Physiol. 19, 124-128.
123. Zucker S. D., Goessling W., Bootle E. J., and Sterritt. (2001) Localization of bilirubin in phospholipid bilayers by parallax analysis of fluorescence quenching. J. Lipid Res. 42, 1377-1388.